Disopyramide induces insulin secretion and plasma glucose diminution: Studies using the in situ canine pancreas
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 38 (2) , 179-183
- https://doi.org/10.1016/0026-0495(89)90259-x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Fasting hypoglycemia associated with disopyramideAmerican Heart Journal, 1983
- Hypoglycemic Coma Due to Disopyramide ToxicitySouthern Medical Journal, 1983
- Hypoglycemia in Patients Receiving Disopyramide PhosphateDrug Intelligence & Clinical Pharmacy, 1983
- Fasting hypoglycemia secondary to disopyramide therapy. Report of two casesPublished by American Medical Association (AMA) ,1981
- Disopyramide (Norpace®)-induced hypoglycemiaThe American Journal of Medicine, 1980
- The Role of Glucagon Deficiency in the Houssay Phenomenon of DogsJournal of Clinical Investigation, 1978
- DisopyramideDrugs, 1978
- Effect of Somatostatin on Pancreatic EndocrineFolia Endocrinologica Japonica, 1976
- Effects of Vagal Stimulation on Glucagon and Insulin SecretionEndocrinology, 1974
- Coated Charcoal Immunoassay of InsulinJournal of Clinical Endocrinology & Metabolism, 1965